PUBLICATIONS 2005 - 2014

Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.

Granado N., O’Shea E., Bove J., Vila M., Colado I. and Moratalla R.
Journal of Neurochemistry 107(4):1102-12 (2008)

Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson’s disease.

Perier C., Bové J., Wu D.C., Jackson-Lewis V., Dehay B., Choi D.G., Rathke-Hartlieb S., Bouillet P., Strasser A., Schulz J.B., Przedborski S. and Vila M.
Proceedings of the National Academy of Sciences USA 104(19):8161-6 (2007)

Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.

Perier C., Tieu K., Guegan C., Caspersen C., Jackson-Lewis V., Carelli V., Martinuzzi A., Hirano M., Przedborski S. and Vila M.
Proceedings of the National Academy of Sciences USA 102(52):19126-19131 (2005)

Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease.

Choi D.-K., Pennathur S., Perier C., Tieu K., Teismann P., Wu D.C., Jackson-Lewis V., Vila M., Von Sattel J.P., Heinecke J.W. and Przedborski S.
Journal of Neuroscience 25(28):6594-600 (2005)

Related Links